Literature DB >> 15875553

False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer.

Jun Maeda1, Mitsunori Ohta, Hirohisa Hirabayashi, Hikaru Matsuda.   

Abstract

We present a case of lung cancer that showed false positive accumulation in an 18F fluorodeoxyglucose positron emission tomography (FDG-PET) scan following induction chemotherapy for suspected metastasis and progression of malignancy. A 66-year-old man was diagnosed with squamous cell carcinoma in the lung, classified as clinical stage IIIA (T2N2M0), and underwent induction chemotherapy. An FDG-PET scan prior to chemotherapy demonstrated accumulation only in the tumor, whereas following treatment it revealed a strong accumulation not only in the tumor, but also in the supraclavicular lymph nodes, which indicated lymph node metastasis. The patient underwent a biopsy of the right supraclavicular lymph node and mediastinoscopy, after which all dissected lymph nodes showed sarcoid reactions and no tumor cells were found pathologically. We concluded that when evaluating the effect of induction chemotherapy for malignancy, a sarcoid reaction might lead to the false positive accumulation of FDG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15875553     DOI: 10.1007/s11748-005-0104-9

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  7 in total

1.  Sarcoid reactions in pulmonary neoplasms.

Authors:  P Laurberg
Journal:  Scand J Respir Dis       Date:  1975-05

2.  Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases.

Authors:  J M Goo; J G Im; K H Do; J S Yeo; J B Seo; H Y Kim; J K Chung
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

3.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.

Authors:  Wolfgang A Weber; Volker Petersen; Burkhard Schmidt; Leishia Tyndale-Hines; Thomas Link; Christian Peschel; Markus Schwaiger
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

4.  Sarcoid reactions in regional lymph nodes of primary lung cancer.

Authors:  K Sugio; T Inoue; H Yokoyama; T Ishida; S Nakano; K Sugimachi
Journal:  Respiration       Date:  1993       Impact factor: 3.580

5.  Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.

Authors:  P J Lewis; A Salama
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

6.  Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy.

Authors:  S B Knight; D Delbeke; J R Stewart; M P Sandler
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

7.  Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.

Authors:  Y Yamada; Y Uchida; K Tatsumi; T Yamaguchi; H Kimura; H Kitahara; T Kuriyama
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

  7 in total
  10 in total

1.  Hilar and mediastinal sarcoid-like reaction after the treatment of malignant tumors: imaging features and natural course on 18F-FDG-PET/CT.

Authors:  Yo Kaneko; Hiroki Kato; Masayuki Matsuo
Journal:  Jpn J Radiol       Date:  2018-10-15       Impact factor: 2.374

2.  Sarcoidosis development during induction chemotherapy for lung cancer mimicked progressive disease.

Authors:  Hideo Umezu; Masayuki Chida; Takashi Inoue; Osamu Araki; Motohiko Tamura; Masamitsu Tatewaki; Yasutsugu Fukushima; Koichi Honma
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-08-12

3.  Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease.

Authors:  Young-Sil An; Joo Sung Sun; Kyung Joo Park; Sung Chul Hwang; Kwang Joo Park; Seung Soo Sheen; Sungsoo Lee; Kyi Beom Lee; Joon-Kee Yoon
Journal:  Lung       Date:  2008-08-01       Impact factor: 2.584

4.  Adenocarcinoma of Ascending Colon Associated with Sarcoid Reaction in Regional Lymph Nodes.

Authors:  Takaaki Fujii; Yuichi Tabe; Reina Yajima; Soichi Tsutsumi; Takayuki Asao; Hiroyuki Kuwano
Journal:  Case Rep Gastroenterol       Date:  2010-03-20

5.  Benign metastasizing leiomyoma.

Authors:  Feride Sapmaz; Makbule Ergin; Ozgur Katrancioglu; Tanseli Gonlugur; Ugur Gonlugur; Sahende Elagoz
Journal:  Lung       Date:  2008-03-21       Impact factor: 2.584

6.  FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment.

Authors:  Kentaro Inoue; Ryoi Goto; Hideo Shimomura; Hiroshi Fukuda
Journal:  Springerplus       Date:  2013-03-15

7.  Sarcoid reaction associated with Merkel cell carcinoma revealed by fluorodeoxyglucose positron emission tomography: a case report.

Authors:  Yuko Higashi; Kentaro Mera; Mitsuyoshi Shimokawa; Mitsuhiro Hisadome; Atsunori Baba; Shigeto Matsushita; Masakazu Yanagi; Takuro Kanekura
Journal:  J Med Case Rep       Date:  2011-07-05

8.  Sarcoidosis in gastric cancer at the time of diagnosis: A case report.

Authors:  Yang Jiao; Jie Ning; Wen-DI Zhao; Yan-Li Li; Hong-Yang Wu; Kang-Sheng Gu
Journal:  Oncol Lett       Date:  2015-01-05       Impact factor: 2.967

Review 9.  Sarcoidosis Occurring After Solid Cancer: A Nonfortuitous Association: Report of 12 Cases and Review of the Literature.

Authors:  Aurélie Grados; Mikael Ebbo; Emmanuelle Bernit; Véronique Veit; Karin Mazodier; Rodolphe Jean; Diane Coso; Thérèse Aurran-Schleinitz; Florence Broussais; Reda Bouabdallah; Gwenaelle Gravis; Anthony Goncalves; Marc Giovaninni; Pascal Sève; Bruno Chetaille; Florence Gavet-Bongo; Thierry Weitten; Michel Pavic; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

10.  Abnormal 18F-FDG Uptake Detected with Positron Emission Tomography in a Patient with Breast Cancer: A Case of Sarcoidosis and Review of the Literature.

Authors:  Selmin Ataergin; Nuri Arslan; Ahmet Ozet; Mehmet Ali Ozguven
Journal:  Case Rep Med       Date:  2009-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.